These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31701773)

  • 1. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis.
    Snoga JL; Lusk KA; Attridge RT; Attridge RL
    Ann Pharmacother; 2020 Apr; 54(4):322-330. PubMed ID: 31701773
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications.
    Bultas AC; Teshome B; Richter SK; Schafers S; Cooke E; Call WB
    Ann Pharmacother; 2020 Jun; 54(6):583-593. PubMed ID: 31810371
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.
    Bossen L; Krag A; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Jun; 63(6):1968-76. PubMed ID: 26599983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.
    Kim BH; Chung JW; Lee CS; Jang ES; Jeong SH; Kim N; Kim JW
    Korean J Intern Med; 2019 Nov; 34(6):1233-1243. PubMed ID: 30759966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis.
    Qi XS; Bao YX; Bai M; Xu WD; Dai JN; Guo XZ
    World J Gastroenterol; 2015 Mar; 21(10):3100-8. PubMed ID: 25780311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
    Pfisterer N; Dexheimer C; Fuchs EM; Bucsics T; Schwabl P; Mandorfer M; Gessl I; Sandrieser L; Baumann L; Riedl F; Scheiner B; Pachofszky T; Dolak W; Schrutka-Kölbl C; Ferlitsch A; Schöniger-Hekele M; Peck-Radosavljevic M; Trauner M; Madl C; Reiberger T
    Aliment Pharmacol Ther; 2018 Apr; 47(7):966-979. PubMed ID: 29388229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonselective Beta-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation?
    Garcia-Tsao G; Abraldes JG
    Gastroenterology; 2021 Sep; 161(3):770-773. PubMed ID: 33989660
    [No Abstract]   [Full Text] [Related]  

  • 9. NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW".
    Dimache M; Gîrleanu I; Carpov E; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):23-8. PubMed ID: 27125068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
    La Mura V; Tosetti G; Primignani M; Salerno F
    World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of acute variceal bleeding: Is being on beta-blockers an aggravating factor? A short-term survival analysis.
    de Souza AR; La Mura V; Berzigotti A; García-Pagán JC; Abraldes JG; Bosch J
    Hepatology; 2015 Dec; 62(6):1840-6. PubMed ID: 26340692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
    Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
    Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
    J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
    Shukla R; Kramer J; Cao Y; Ying J; Tansel A; Walder A; Advani S; El-Serag HB; Kanwal F
    Am J Gastroenterol; 2016 Dec; 111(12):1778-1787. PubMed ID: 27670600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
    Garcia-Guix M; Ardevol A; Sapena V; Alvarado-Tápias E; Huertas A; Brujats A; Fajardo J; Cuyas B; Poca M; Guarner C; Torras X; Escorsell À; Villanueva C
    Liver Int; 2024 Aug; 44(8):1971-1989. PubMed ID: 38634685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
    Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
    Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.
    Villanueva C; Sapena V; Lo GH; Seo YS; Shah HA; Singh V; Tripathi D; Schepke M; Gheorghe C; Bonilha DQ; Jutabha R; Wang HM; Rodrigues SG; Brujats A; Lee HA; Azam Z; Kumar P; Hayes PC; Sauerbruch T; Chen WC; Iacob S; Libera ED; Jensen DM; Alvarado E; Torres F; Bosch J;
    Aliment Pharmacol Ther; 2024 Feb; 59(3):306-321. PubMed ID: 38108646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.